The Effects of Moderate-Severe Plaque Psoriasis on Patient Well-Being and Prevention of Flares by Devera, Glenn
Dominican Scholar 
Nursing | Senior Theses Department of Nursing 
12-2020 
The Effects of Moderate-Severe Plaque Psoriasis on Patient Well-
Being and Prevention of Flares 
Glenn Devera 
Dominican University of California 
Survey: Let us know how this paper benefits you. 
Recommended Citation 
Devera, Glenn, "The Effects of Moderate-Severe Plaque Psoriasis on Patient Well-Being and 
Prevention of Flares" (2020). Nursing | Senior Theses. 12. 
https://scholar.dominican.edu/nursing-senior-theses/12 
This Senior Thesis is brought to you for free and open access by the Department of Nursing at 
Dominican Scholar. It has been accepted for inclusion in Nursing | Senior Theses by an authorized 
administrator of Dominican Scholar. For more information, please contact 
michael.pujals@dominican.edu. 
Running Head: PATIENT WELL-BEING AND THE EFFECT OF PSORIASIS   1
The Effects of Moderate-Severe Plaque Psoriasis on  
Patient Well-Being and Prevention of Flares 
Glenn Devera 
Dominican University of California 
NURS 4500 
Dr. Patricia Harris 
August 24, 2020  
Running Head: PATIENT WELL-BEING AND THE EFFECT OF PSORIASIS   2
Abstract 
Psoriasis is a chronic skin condition that is indicated by red, patchy and scaly skin that 
can be painful when irritated. Patients with psoriasis have an increased risk for a number of  
chronic diseases. Despite the expansion of treatments for moderate-to-severe psoriasis over the 
last decade, patients may still find that treatment strategies are not as successful, leaving them 
dissatisfied with their treatments. A relationship built upon trust between the nurse and the 
patient diagnosed with psoriasis may serve to help ensure optimal care.  
A comprehensive literature review was performed and found that best practices for 
patient management need to include education that covers information regarding treatments, 
biological therapies, optimizing patient fidelity to treatment, and management of other side 
effects/ comorbidities. 
A study is proposed to investigate the impact of the nurse-patient relationship on patients’ 
perceptions about their disease management in relation to psoriasis and outcomes of care.  
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Introduction 
Psoriasis is a chronic skin condition that is indicated by red, patchy and scaly skin that 
can be painful when irritated. Patients with psoriasis have an increased risk for more than one 
chronic disease such as Psoriatic Arthritis, Crohn’s Disease, Psychological Disorders, 
Hypertension, Diabetes, and Heart Disease, which may emerge due to the buildup of plaques 
along with chronic inflammation (Aldredge, & Young, 2016). Despite the expansion of 
treatments for moderate-to-severe psoriasis over the last ten years, alleviation of symptoms 
remains suboptimal.  
Patients often find that their therapies are not as successful, leaving them dissatisfied with 
their treatments (Takeshita et al., 2014). A trusting relationship between the nurse and the patient 
diagnosed with psoriasis must be built to ensure optimal and appropriate plans of care.  
In this thesis, a comprehensive literature review was performed and found that best 
practices for patient management need to include education that covers information regarding 
treatments, biological therapies, optimizing patient fidelity to treatment, and management of 
other side effects and comorbidities. 
A qualitative study of patients and nurses is proposed to investigate the impact of the 
nurse-patient relationship on patients’ perceptions about the disease management in relation to 
psoriasis and outcomes of care. In addition, the proposed study will explore patients' and nurses" 
perceptions of experiences that contribute to exacerbation and strategies that may work to 
improve symptoms and quality of life.  
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Literature Review 
 The research literature was searched by looking through the various databases using the 
Dominican University of California’s Library, including MedLine, IceBerg, CINAHL, and 
Elsevier. Seven primary research articles were compiled to review the issue of psoriasis. 
Keywords included: psoriasis, chronic, stress, Psoriasis Area and Severity Index, psychological 
distress, Quality of life and Dermatology Life Quality Score Index. 
 The literature review section of this paper is divided into two categories. The first 
category notes the overlying causes of psoriasis and shows how psoriasis is exacerbated. The 
second category goes into the treatments (pharmacological and nonpharmacological) available 
for a person who has moderate-to-severe plaque psoriasis. Please see Appendix A for a table 
summarizing the studies. 
Psoriasis: Causes & Exacerbation 
The Role of Stress in Children with Psoriasis 
The article The Role of Stress in Children with Psoriasis by Manolache, L., Petrescu-
Seceleanu, D., & Benea, V. (2012) is an observational study that was to make note of any 
stressful situations that happen before or after the onset of psoriasis in children that were 16 
years of age or younger. This article was drawn from the database Sagepub from the National 
Psoriasis Foundation. Some of the keywords that were used were psoriasis; stress; and children. 
The sample size used was Boys (n=18) and Girls (n=23) with a total of (n=41) who are 16 years 
old or less within the study. Data was collected from 2001 to 2007. The design of the study is 
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comparative/ correlational where the author attempted to observe if stress is one of the main 
factors of psoriatic flares between boys and girls.  
 The purpose of this article was to study was to observe if there were any stressful 
situations within children’s lives which contributed to the extension or onset of their psoriasis. 
The findings from the article suggest that the incidence of psoriasis among other new 
dermatological conditions or morbidities was 0.43% , noting that the average age of children was 
11.97 years (Manolache, Petrescu-Seceleanu, & Benea, 2012). In 29.26% of the cases, a family 
history of psoriasis was accounted. 31% of the children with psoriasis had a flare up less than 3 
months before the evaluation and 38% had recently had new occurrences or extensions 
(Manolache, Petrescu-Seceleanu, & Benea, 2012). 14.6% of the cases noted that inflammation 
was a focus and 41% of the cases noted that stress was a factor in contribution to their psoriasis 
(Manolache, Petrescu-Seceleanu, & Benea, 2012). Most of these children mentioned at least one 
event that may have affected their development of psoriasis. Boys with guttate lesions and girls 
with psoriasis vulgaris were most affected by stress. Family problems such as disputes, illnesses, 
financial restrictions, and death were often brought up under the stress category. It is also noted 
that school plays a factor which influences psoriatic lesions.  
 The nursing implication for this article shows the importance of making sure patients are 
stress free hospitalized or not, to help to contribute in the slowing/ healing process of their 
psoriasis. A nurse-patient relationship must be built in order to maintain optimum levels of 
rapport. One limitation of this article notes that the recollection of past events from the patient or 
the patient’s family may not be consistent. In conclusion, the presence of stressful situations can 
be considered influential in the extension of psoriasis in children. 
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Association Between Psoriasis and Health-Related Quality of Life 
The article The Association Between Psoriasis and Health-Related Quality of Life, 
Work, Productivity, and Healthcare Resource use in Brazil by DiBonaventura, M., Carvalho, A., 
Souza, C., Squiassi, H., & Ferreira, C. (2018, March) is a quantitative study/ survey which 
helped to monitor the correlation between psoriasis and the psychological/ humane and lucrative 
burden among the people living in Brazil. The article was taken from the database PubMed from 
the National Center for Biotechnology Information. Some of the keywords that were used were 
Psoriasis; Health Impact Assessment; Quality of Life and Health Resources. The sample size 
used were (n=12,000) Surveys which were given to people to assess work productivity, available 
healthcare resources, and quality of life with present psoriasis skin conditions vs. no present skin 
condition. Data was collected in 2012 using the Brazil 2012 National Health and Wellness 
Survey (NHWS), which was a survey which focused on the health of adults ages 18 and older in 
Brazil. Use of the Internet combined with the Computer-Assisted Web Interviewing or CAWI 
was needed to lower the bias rates of people who had access or no access to the internet 
regarding the older population. 
The purpose of this study was to use surveys to measure Sociodemographics, Health 
History, Work and Activity Impairment, and Healthcare Resource Use among people who have 
or do not have psoriasis within Brazil. Results show that a total of 210 people that responded had 
a diagnosis of psoriasis (n=157, 42, and 11) (DiBonaventura, Carvalho, Souza, Squiassi, & 
Ferreira, 2018). It was also noted that reports of mild, moderate, and severe forms of psoriasis 
were present. (DiBonaventura, Carvalho, Souza, Squiassi, & Ferreira, 2018). These respondents 
had noted low health utilities, with a decrease in efficiency at work, impairment of daily 
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activities, and a low number of physician visits over the last six months (DiBonaventura, 
Carvalho, Souza, Squiassi, & Ferreira, 2018). Physical health also deteriorated as severity of skin 
disease increased. Psoriasis severity was no different when factors regarding utilization of 
healthcare re- sources and work efficiency came into play,  showing a high probability for 
economic burden (DiBonaventura, Carvalho, Souza, Squiassi, & Ferreira, 2018). 
The nursing implication for this article supports that stress is a huge factor in psoriatic 
flares and shows a significant burden to patients who have psoriasis across both economic and 
humanistic ends. Limitations of this article were that cost analyses were not examined and the 
cross sectional patient responses may have bias. In conclusion, the study further verifies that life 
stressors and psoriasis are not compatible.  
The Associations Between Psychological Stress and Psoriasis: A Systematic Review 
The article The Associations Between Psychological Stress and Psoriasis: A Systematic 
Review by Thomas Stewart, Winnie Tong, and Margot Whitfeld (2018) is a correlational/ 
comparative study that tries to determine if there is a link between psychological stress as the 
predictor and onset or extension of psoriasis. Their second objective was determining if there is a 
relationship between the severity of psychological stress and severity of psoriasis. This article 
was drawn from the database Wiley from the International Journal of Dermatology. Some of the 
keywords used were psoriasis, stress, stress psychological; psychological distress; mental strain; 
or mental distress. The sample size used were (n=19,617) people who were included in cross-
sectional, case-control, and cohort studies who were 16 years or older with a diagnosis of 
psoriasis. Data was collected from 1987 to 2016. 
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The purpose of this study was to find any links between the presence of psychological 
stress and how it impacts psoriasis severity.  The study extracted data based on factors such as 
age, gender, other dermatological conditions, proportioning of patients with psychological stress 
predicting, onset, recurrence, and severity of psoriasis with individual reports of stress measures 
(MJ;, 2018). Results showed that the largest available epidemiological study noted 7992 
diagnoses of psoriasis in Italy. 27% of these cases self reported that their psoriasis had been 
triggered by “stressful events”(MJ;, 2018). The study also indicated that the influence of 
psychological stress on psoriasis extension happened to another 35% of patients noting that the 
onset had occurred during a “stressful period”, and that 66-71% stated their psoriasis was 
significantly affected by stress (MJ;, 2018). Overall epidemiological rates of stress related 
psoriasis range from 27-71% (MJ;, 2018). 
The outcome of this article suggests that there is a significant correlation between 
using psychological stress as a predictor of psoriatic extension periods. Limitations of this study 
included the use of patients that were recruited from hospital outpatient departments which limit 
validity. In addition, environmental stressors affect every individual differently in which stressful 
events could be discriminated against.  
Outcomes in Psoriasis Patients with Clear Versus Almost Clear Skin in the Clinical Setting 
The article Patient-Reported Outcomes in Psoriasis Patients with Clear Versus Almost 
Clear Skin in the Clinical Setting by Takeshita et al. (2014) compares the quality of life between 
patients with clear skin vs. patients with psoriasis. This article was drawn from the database 
Iceberg from the National Center for Biotechnology Information. Some of the keywords used 
were Psoriasis; Quality of life; Dermatology Life Quality Index; Physician Global Assessment; 
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and Psoriasis Area and Severity Index. The sample size used was (n=97) patients with clear skin 
vs. (n=441) patients with almost clear skin with a total of (n=538). The design of the study was a 
correlational/ Comparative study which consisted of 97 patients with clear skin and 441 patients 
with almost clear skin but are receiving UV light therapy.  
 The purpose of this article was to observe and record the results of Dermatology Life 
Quality Index Scores of patients with clear skin vs. almost clear skin (Takeshita et al., 2014). The 
results showed that patients with clear skin noted psoriasis did not affect their quality of life 
(relative risk 1.60; 95% confidence interval, 1.37–1.86) vs. versus people with almost clear skin 
(Takeshita et al., 2014). Patients with clear skin also denied use of topical prescriptions (relative 
risk 2.08; 95% confidence interval, 1.73–2.49) (Takeshita et al., 2014). Both men and women 
were close to being equally balanced from the two groups. Majority of patients were Caucasian. 
Alcohol consumption was significantly different with patients with clear skin reporting no 
alcoholic drinks in the past year (45.4%) versus almost clear skin (27.4%) (p=0.001) (Takeshita 
et al., 2014).  
 The nursing implication of this article supports that patients’ with psoriasis report lower 
quality of life. Some limitations of this article suggest that the cross-sectional design does not 
allow long term or longitudinal study. Topical medication use and quality of life were 
significantly different between these two groups.  
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Available treatments (pharmacological and nonpharmacological) for plaque psoriasis 
Patient Satisfaction with Treatments for Plaque Psoriasis in Clinical Practice 
The article Patient Satisfaction with Treatments for Moderate-to-Severe Plaque Psoriasis in 
Clinical Practice by Horn et al. (2008) is an Online Survey/ Quantitative study which was to 
measure the satisfaction of treatment among people diagnosed with psoriasis. This article was 
taken from the database Iceberg from the National Center for Biotechnology Information. The 
sample size used was taken from the Dermatology Clinical Effectiveness Research Network 
which consisted of (n=1182) patients with moderate-to-severe psoriasis. The design of the study 
was cross sectional/ comparative study which looked at treatment efficacy for moderate-to-
severe psoriasis. The data was taken by 12 clinicians.  
 The purpose of this article was to measure overall satisfaction of treatment. The results 
show that patients receiving biological therapies, UV light, and methotrexate prescriptions have 
higher satisfaction scores (83.3). Patients only utilizing topical medications had lower scores 
(66.7) (Horn et al., 2008).  
 The nursing implication for this article notes that patients who receive non-topical 
medications have better satisfaction ratings as compared to patients who took topicals. 
Limitations of this study show that a sample population was taken from a preset consumer panel 
then using random sampling. The panel was to represent the whole Canadian population, but no 
one in the panel was eligible and lived in the territories. Territorial population was not well 
represented. In conclusion, there were noticeable differences found in treatment satisfaction 
among different therapies for psoriasis with an emphasis on effectiveness and convenience. 
Treatment decisions and guideline developments must be implemented to improve study.  
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Efficacy and safety of apremilast in patients with plaque psoriasis of the scalp 
 The article Efficacy and safety of apremilast in patients with moderate to severe plaque 
psoriasis of the scalp by (Voorhees et al., 2020) is a multicentered, double blind, randomized, 
placebo-controlled study which was to evaluate the effectiveness of Apremilast (Otezla) for 
people with moderate-severe psoriasis of the scalp (Voorhees et al., 2020). This article was taken 
from the database Iceberg from the Journal of the American Academy of Dermatology. Some of 
the keywords used were: apremilast; psoriasis; quality of life; itching; pruritus; and scalp. The 
sample size used were (n=303) total randomized patients, (n=102), receiving placebo, (n=201) 
receiving apremilast. Patients were at least 18 years or older. Data was collected from May 2017 
to January 2019. The design of the study is a phase 3, multicentered, double blind, randomized, 
placebo-controlled study (Voorhees et al., 2020). 
 The purpose of this article was to observe the safety and effectiveness of the medication 
apremilast (Otezla) on people diagnosed with moderate-severe plaque psoriasis of the scalp. The 
results show that patients who took apremilast vs. patient with the placebo achieved a (43.3% vs. 
13.7$) clearance rate based on the Physician Global Assessment regarding severity of psoriasis 
(Voorhees et al., 2020). There were also significant results based on the Scalp Itch NRS with 
(47.1%) patients taking apremilast) noting that their itching has been reduced as compared to the 
placebo group with (21.1%) (Voorhees et al., 2020). Whole Body Itch NRS also noted a (45.5%) 
itch reduction in people who took the medication, as opposed to the placebo (22.5%) (Voorhees 
et al., 2020). The Dermatology Quality of Life Index scores indicate that people who took the 
medication apremilast noted that there was a significant difference in skin clearance (6.7) as 
compared to the placebo group (3.8) noting little clearance of psoriasis (Voorhees et al., 2020).  
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 The nursing implications of this article indicate that use of apremilast can result in having 
side effects of diarrhea (30.5%), nausea (21.5%), headaches (12.0%), and vomiting (5.5%) 
(Voorhees et al., 2020). Limitations of this article are that people with mild psoriatic spread were 
not indicated/ observed. In conclusion, this study shows a significant decrease in psoriatic spread 
of the scalp vs. people who do not take the medication apremilast (Otezla).  
Aggressive weight-loss program with a ketogenic phase for treatment of plaque psoriasis 
 The article Aggressive weight-loss program with a ketogenic induction phase for the 
treatment of chronic plaque psoriasis by (Castaldo et al., 2020) is a single arm, open label trial 
where they evaluate the effectiveness of a weight loss program with the integration of a 
ketogenic diet for treatment of chronic plaque psoriasis. This article was taken from the database 
Iceberg from ScienceDirect. Some of the keywords are chronic plaque psoriasis; PASI; ketogenic 
diet; mediterranean diet; and weight loss. The sample size used was (n=37) adult patients who 
were either overweight/ obese and have never used any medication besides topical creams. All 
patients were diagnosed with chronic plaque psoriasis. The study consisted of 30% men and 70% 
female. The design of the study is a single-arm, open clinical trial.  
 The purpose of this study was to observe the effects of a weight loss program combined 
with the use of a ketogenic diet to be used as a first line treatment for chronic plaque psoriasis 
(Castaldo et al., 2020). Methods show that all of the patients went through a ten week, two phase 
weight loss program. The program consisted of four weeks of a protein sparing, very low calorie 
ketogenic diet, and a six week hypocaloric Mediterranian-like diet (Castaldo et al., 2020). The 
results show that there was an average body weight reduction of 12% (10.6 kg),  strong reduction 
in the Psoriasis Area and Severity Index (PASI) (> 50% and >75%), and overall better scores 
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within itch severity and the Dermatology Life Quality Score Index (DLQI)(-13.4 points) 
(Castaldo et al., 2020).  
 The nursing implications of this article show the correlation between obesity and the 
spread of psoriasis influencing quality of life. Body image can be maintained through use of 
consistent exercise, further reducing buildup of plaque psoriasis. Visceral adipose tissue is the 
main source of adipocytokines, which stimulate the immune response. The use of a weight loss 
program with a low-calorie ketogenic diet proves an effective treatment for psoriasis.  
Proposal for Further Study 
Overall Research Question and Rationale   
 The question that arises from the research is - what is the effect of nursing education on 
patients who have moderate-to-severe plaque psoriasis and how it can be changed to further 
implement a reduction on psoriatic flares and what are patient perceptions based on the different 
amount of therapies available? According to the literature review, it seems that there is an 
overwhelmingly strong focus on stress and how it affects people with psoriasis and makes their 
flaring episodes worse. When we take in account the patient as a whole, looking at their vitals, 
medical history, age, social background, economic standings (such as debt), employment, etc. We 
can try and isolate the main causes of stress within the client and see if we could provide support 
in order to reduce the overall spread of their psoriasis. In terms of medications, we also need to 
observe strength of therapy and consistency for optimal effectiveness. The purpose of this study 
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is to look at the nurse-patient relationship and how it affects the patient’s underlying skin 
condition, while at the same time noting the consistency of treatments/ therapies. The author 
hopes that this study can be beneficial for dermatological nurses and especially patients suffering 
with plaque psoriasis to see potential results and get the help they need for faster clearance of the 
disease.  
Theoretical Framework 
 The theorist that most relates to this study is Faye G. Abdellah and her theory of Patient-
Centered Approaches to Nursing. Abdellah was the first nurse officer to earn the rank of a two 
star Rear Admiral and was also the first nurse and woman to serve as a Surgeon Deputy General 
during the Korean War (21 Nursing Problems). Her work within nursing was able to change the 
focus from disease-centered to patient-centered care. The Patient Assessment of Care Evaluation 
(also known as ADPIE) that she had developed is used across the United States and is considered 
the standard among nursing care in modern society. Abdellah believes that health is a state 
mutually exclusive of illness. She also states that there is no definition of health but points 
toward a patient's overall health needs and grounded mental foundation in her description of 
nursing as a service (21 Nursing Problems). Her goal of centering patient care ultimately looks at 
what the patient is feeling “right now” instead of the progress of their disease or injury. For 
psoriatic patients, this should be the standard that must be upheld because of how there are 
plenty of factors that can affect their underlying skin condition. 
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Primary Research Aims 
- To observe nurse-patient relationship quality and status of psoriasis 
- Note effectiveness and consistency of pharmacological and nonpharmacological therapies 
for psoriasis 
Ethical Considerations 
 The proposed study will be reviewed for ethical considerations a by the university and the 
facilities internal review board before data collection begins. After approval, potential 
participants will be informed of their rights and provided information about the study. The study 
will ensure the privacy of clients and nurses who participate in the study. Informed consent will 
be obtained. Clients have the right to withdraw from the study if they choose. The nurse and 
client must agree to keep all information confidentiality. Confidentiality of the research study 
data will be ensured.  
Research Method 
Type of Study 
Descriptive - Phenomenology Qualitative Study involving the patient with psoriasis and the 
dermatological nurse working in conjunction with the said patient. This study will be 
conducted by using interviews to find out about each client’s quality of life living with 
psoriasis. The client's nurse also can give insight on various strategies they can implement 
when caring for these patients.  
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 Therefore, after the study is explained, questions answered, and informed consent 
obtained, clients and their nurses will be interviewed as a dyad whenever possible. If the 
interviews cannot take place with both client and nurse present at the same time, then clients 
and nurses will be interviewed separately. 
 The interviews will use qualifying questions to narrow the target population and see if 
they are eligible for an interview, such as whether or not the person has been diagnosed with 
psoriasis, length of time since initial diagnosis, location of residence (in San Francisco or 
not), whether or not the client's age is greater than 18 years, status as student or working 
adult, or if the potential participant a nurse who cares for the psoriasis clients. 
Sample 
1) Patients diagnosed with psoriasis - Inclusion criteria: 
- Any patient with moderate-to-severe plaque psoriasis lasting for at least 5 years 
- Patient must live in the San Francisco Bay Area  
- Minimum age = 18  
- Student or working adult 
- Any socioeconomic status 
2) Nurses who care for clients diagnosed with psoriasis - Inclusion criteria: 
- Any nurse working with an eligible patient 
Proposed Sample Size 
- The proposed sample size of this study is 10 patients diagnosed with psoriasis and 10 
nurses who care for patients diagnosed with psoriasis 
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Strategy for Recruitment 
 Once the clients who are eligible for the interview are selected, they will be asked to meet 
on a mutually convenient date to conduct the interview. Clients who are eligible but are in the 
hospital will be able to have a one-on-one interview with the researcher. The semi-structured 
interviews will ask questions regarding certain stressors in the client's life such as 
socioeconomic status, employment status, social and family history, therapies 
(pharmacological and non-pharmacological), and progression of psoriasis. The client's nurse 
may also be interviewed and asked to offer nursing strategies to alleviate psoriasis symptoms 
and help the researcher gather insights. The interviews are expected to last approximately 45 
minutes. 
Data Analysis 
A qualitative content analysis will be performed, including: 
- Identification of similar words and phrases 
- Organization into categories 
- Description of themes  
Conclusion 
 The review of the research literature revealed several common threads. These include: 
● Stress may be a precipitator of symptoms and exacerbation 
● The problem may be more prevalent among patients of low socioeconomic class  
● Lack of knowledge regarding therapies is often cited as a need 
● Limiting the severity of psoriatic flares is an ongoing need.  
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 Furthermore, effective communication and encouragement of patient receptiveness are 
essential for understanding patient needs within the nurse-patient relationship. Building 
rapport early on within a patient's stay can further ease the patient to provide the optimal 
care. In a clinical setting, nurses must be able to be empathetic to their patients to understand 
their needs. If a patient has other problems other than their underlying medical conditions, 
the nurse must be able to offer support/ point clients in the right direction through use of 
other resources relating to economic support, psychiatric help, etc.  
 By questioning the nurse-patient relationship and observing the various therapies for 
patients with psoriasis, this research could potentially help nurses become more effective in 
caring for patients with this disease.  
 The proposed study aims to learn more about the economic statuses of clients affected. 
There may be variability or bias within these results, so narrowing the target population could 
prove much more beneficial for the study. A correlation must be found to further find an 
observational target population. 
 In the future, a survey to compare patients’ perceptions of two different educational 
programs, one in pharmacological therapies and the other in non-pharmacological therapies 
may a reasonable step toward finding the most effective treatments for psoriasis.  
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Manolache, L., Pe-
trescu-Seceleanu, D., 
& Benea, V. (2012). 
The role of stress in 
children with psori-
asis. Psoriasis Fo-
rum, 18a(1), 22-25. 
doi:10.1177/2475530
31218a00103
The purpose of the 
study was to note 
any stressful situa-
tions that occur 
before the onset or 
extension of psoria-
sis in children aged 
16 years and 
younger.
N = 41 Correlational/ Com-
parative/  
Quantitative
The study comprised 
41 children (23 girls, 
18 boys) with psori-
asis who were en-
rolled in a compara-
tive study.
- The incidence of 
psoriasis among 
new dermatologic 
conditions was 
0.43%.  
- The mean age of 
the children was 
11.97 years.  
- There was a family 
history of the dis-
ease in 29.26% of 
cases; 31% of 
children with pso-
riasis had onset of 
psoriasis less than 
3 months before 
the evaluation, and 
38% had recent 
extensions or re-
currence.  
- In 14.6% of psori-
asis cases, an in-
flammatory focus 
was identified. 
- Stressful events 
had occurred in 
41% of the psoria-
sis group, com-
pared with 17% of 
controls.
- Provides demo-
graphic data, stress-
ful events in relation 
to school and educa-
tion, familial issues, 
personal events, and 
psychosocial trau-
ma.
- The recollection of 
past events within 
the patient's family 
or by the patient and 
the dimensions of 
the sample could not 
be consistent
Appendix
DiBonaventura, M., 
Carvalho, A., Souza, 
C., Squiassi, H., & 
Ferreira, C. (2018, 
March). The Associ-
ation between psori-
asis and health-re-
lated quality of life, 
work productivity, 
and Healthcare 
resource use in 
Brazil. Retrieved 
February 11, 2020, 
from https://
www.ncbi.nlm.nih.-
gov/pmc/articles/
PMC5916390/
The current study 
contributes to the 
psoriasis outcomes 
literature by offer-
ing a comprehensive 
assessment of the 
humanistic and 
economic burden in 
Brazil. 
N = 12,000 Survey/ 
Quantitative
The 2012 Brazil 
National Health and 
Wellness Survey 
(N=12,000) was used 
to assess health-
related quality of life 
(Short Form-12, 
version 2), work 
productivity, and 
healthcare resource 
use associated with 
experiencing psoria-
sis vs. no psoriasis, 
along with varying 
levels of psoriasis 
severity. 
Nevertheless, these 
results suggest a 
significant burden to 
patients with psoria-
sis across both hu-
manistic and eco-
nomic outcomes. 
The association 
between psoriasis 
and mental health 
aspects and health 
utilities were partic-
ularly strong and 
exceeded what 
would be considered 
clinically meaning-
ful.

- Large sample size 
- Data were collect-
ed using a dual 
methodology of 
Internet and com-
puter-assisted Web 
interviewing 
(CAWI). This dual 
approach was used 
to minimize bias 
related to Internet 
access, particular-
ly among the el-
derly
Cost analyses were 
not performed, and 
cross-sectional pa-
tient-reported data 
limit causal conclu-
sions and may re-
flect reporting bias-
es. 
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MJ;, S. (n.d.). The 
Associations Be-
tween Psychological 
Stress and Psoriasis: 
A Systematic Re-
view. Retrieved from 
https://
pubmed.ncbi.nlm.ni
h.gov/29516474-the-
associations-be-
tween-psychological-
stress-and-psoriasis-
a-systematic-review/ 
**Open 
through Ale-
many Lib > 
Pub Med > 
Wiley
The primary objec-
tive of this review 
was to determine 
whether there exists 
a temporal associa-
tion between psycho-
logical stress as the 
predictor and onset 
and/or recurrence of 
psoriasis as the out-
come measure. Our 
secondary objective 
was to establish 
whether there is a 
relationship between 
the degree of psy-
chological stress and 
clinical severity of 
psoriasis
N = 19,617 Correlational/ Com-
parative/ 
Quantitative
We included cross-
sectional, case-control, 
and cohort studies 
involving adult (16 
years or older) patients 
with a clinical and/or 
histological diagnosis of 
psoriasis. Psychological 
stress was assessed by 
the presence of self-
reported stress, stress-
ful life events on event 
scales, or the presence 
of stress on self-report-
ed rating scales. A 
rapid assessment to 
determine basic eligibil-
ity was performed 
using the approach 
described by Michael 
al.6Studies were scored 
based on five design 
criteria using a scale of 
0 or 1 (superior). The 
five criteria were ap-
propriateness and 
reporting of inclusion 
and exclusion criteria, 
assessment of outcome 
control of confounding 
and evidence of bias. 
Lower quality studies 
score 0–3 and higher 
quality studies 4–5. 
Only higher quality 
studies were included.
Our systematic re-
view demonstrates a 
probable temporal 
association between 
different measures 
of psychological 
stress and onset, 
recurrence and 
severity of psoriasis
- Mixture of various 
studies such as cross 
sectional, case con-
trol, cohort studies, 
patient with clinical 
disorders, and pa-
tients with histologi-
cal diagnosis of 
psoriasis.
Most participants were 
recruited from hospital 
outpatient depart-
ments, limiting external 
validity. Included 
studies used a number 
of different methods to 
measure psychological 
stress which introduced 
heterogeneity in our 
outcomes assessments. 
In addition, an individ-
ual’s reaction to an 
environmental stressor 
depends on how stress-
ful they perceive it to 
be, for which life events 
scales can be poorly 
dis-criminatory. Mental 
health conditions are 
associated with higher 
baseline stress 
levels,29and none of the 
included studies active-
ly screened for psychi-
atric disorders. Studies 
asked subjects to re-
member life events up 
to 12 months prior to 
onset and/or recurrence 
of their psoriasis intro-
ducing recall bias.
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Takeshita, J., Callis 
Duffin, K., Shin, D., 
Krueger, G., Robert-
son, A., Troxel, A., . . 
. Gelfand, J. (2014, 
October). Patient-
reported outcomes 
for psoriasis patients 
with clear versus 
almost clear skin in 
the clinical setting. 
Retrieved February 
11, 2020, from 
https://
www.ncbi.nlm.nih.-
gov/pmc/articles/
PMC4165851/ 
To compare Derma-
tology Life Quality 
Index scores and 
prescription topical 
medication use be-
tween patients with 
clear versus almost 
clear skin.
N = 538 Correlational/ Com-
parative/ 
Descriptive/ 
Quantitative
Multicenter cross-
sectional study of 97 
patients with clear 
skin and 441 pa-
tients with almost 
clear skin receiving 
current systemic 
therapy or pho-
totherapy for a pri-
mary indication of 
plaque psoriasis 
evaluated at one of 
ten US outpatient 
dermatology sites 
participating in the 
Dermatology Clini-
cal Effectiveness 
Research Network.
In adjusted analyses, 
patients with clear 
versus almost clear 
skin were more 
likely to report no 
impact of psoriasis 
on quality of life 
(relative risk 1.60; 
95% confidence 
interval, 1.37–1.86). 
Patients with clear 
versus almost clear 
skin were also more 
likely to report no 
prescription topical 
medication use in 
the preceding week 
(relative risk 2.08; 
95% confidence 
interval, 1.73–2.49).
- Broad inclusion 
criteria, patient 
population drawn 
from multiple clini-
cal practices across 
the United States, 
and use of multi-
variable statistical 
models to account 
for potential con-
founding factors
Cross-sectional 
design prohibits 
longitudinal assess-
ment of outcomes. 
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Horn, E. J., Fox, K. 
M., Patel, V., Kim-
ball, A. B., Gordon, 
K. B., & Lebwohl, 
M. G. (2008). 
Treatment satisfac-
tion and HEALTH-
RELATED quality 
of life among indi-
viduals WITH Pso-
riasis: National 
Psoriasis Founda-
tion survey findings. 
Psoriasis Forum, 
14a(2), 27-34. 
doi:10.1177/2475530
30814a00205 
To describe practice 
patterns for care of 
Canadian patients 
with moderate to 
severe plaque psori-
asis. 
N = 3845 Online Survey/ 
Quantitative
A population-wide, 
cross-sectional sam-
ple representative of 
the adult Canadian 
population and 
balanced by region 
and sex was identi-
fied using propri-
etary consumer 
databases. These 
databases consisted 
of information on 
members of the 
general public who 
had consented to be 
contacted to com-
plete surveys volun-
tarily. E-mail invita-
tions were sent to a 
national sample of 
3845 Canadian 
adults (≥ 18 years) 
with self-reported 
psoriasis
Overall physician care was 
reported to be satisfactory 
by 62% of respondents. 
Most respondents receiving 
over-the-counter therapies 
(55%) or prescribed topical 
therapies (61%) reported 
that their psoriasis was 
managed by FPs. Respon-
dents receiving prescription 
oral or injectable medica-
tions or phototherapy were 
mainly managed by derma-
tologists (42%, 74%, and 
71% of respondents, 
respectively). Ongoing 
management of respon-
dents with body surface 
area involvement of 10% or 
greater was mainly split 
between dermatologists 
(47%) and FPs (45%), 
compared with rheumatol-
ogists (4%) or other health 
care professionals (4%). Of 
those respondents receiving 
medications for concomi-
tant health conditions, 
treatment for high blood 
pressure was most common 
(92%), followed by treat-
ment for heart disease 
(75%) and elevated choles-
terol and lipid levels (68%).
- Regions of popula-
tion was organized 
and balanced 
based by region 
and sex.
Limitations of this 
study included a 
sample population 
derived from a pre-
existing consumer 
panel rather than by 
random sampling. 
The consumer panel 
was constructed to 
represent the gener-
al Canadian popula-
tion, but no eligible 
panelists lived in the 
territories. As a 
result, the territorial 
population was not 
represented, al-
though it is known 
that most Canadians 
(99.68%) reside 
within the provinces
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Castaldo, G., Ras-
trelli, L., Galdo, 
G., Molettieri, P., 
Aufiero, F. R., & 
Cereda, E. (2020). 
Aggressive 
weight-loss pro-
gram with a keto-
genic induction 
phase for the 
treatment of 
chronic plaque 
psoriasis: A proof-
of-concept, single-
arm, open label 
clinical trial. Nu-
trition, 74, 110757. 
doi:10.1016/
j.nut.2020.110757 
A very low-calorie 
ketogenic diet 
(VLCKD) has 
been associated 
with a significant 
reduction in vis-
ceral adipose tis-
sue and ketone 
bodies that likely 
possess antiin-
flammatory prop-
erties. We evalu-
ated the efficacy 
of an aggressive 
weight-loss (WL) 
program with a 
ketogenic induc-
tion phase as first-
line treatment for 
chronic plaque 
psoriasis.
n = 37 Single-arm, Open 
Label Trial
Adult patients who 
were overweight or 
obese and drug-
naïve with stable 
chronic plaque pso-
riasis underwent a 
10-wk, 2-phase WL 
program consisting 
of a 4-wk protein-
sparing, VLCKD 
and 6-wk balanced, 
hypo caloric, 
Mediterranean-like 
diet. The primary 
endpoint was the 
reduction in Psoria-
sis Area and Severity 
Index (PASI) score 
at wk 10. Major 
secondary endpoints 
included PASI score 
responses of 50% 
and 75%, reduction 
in body surface area 
involved, improve-
ment in itch severity, 
and Dermatology 
Life Quality Index 
score at wk 10.
With a mean body 
weight reduction 
of 12.0% (10.6 
kg), the dietary 
intervention re-
sulted in a signifi-
cant reduction in 
PASI (baseline 
score: 13.8 § 6.9; 
range, 732), with a 
mean change of 
10.6 (95% confi-
dence interval, 
12.8 to 8.4; P < 
0.001). PASI score 
responses of 50% 
and 75% were 
recorded in 36 
patients (97.3%) 
and 24 patients 
(64.9%), respec-
tively. Treatment 
also resulted in a 
significant reduc-
tion (P < 0.001) in 
the body surface 
area involved 
(17.4%) and an 
improvement in 
itch severity (33.2 
points) and Der-
matology Life 
Quality Index 
score (13.4 points)
- Study has a 
small sample size, 
resulting in better 
close observation/ 
analyzation of 
data
The main limita-
tion of the study is 
the open-label, 
single-arm design, 
which could be 
associated with an 
overestimation of 
treatment effects, 
although the 
analysis was based 
on the evaluation 
of major efficacy 
endpoints by 2 
independent der-
matologists
Authors/Citation Purpose/Objective of 
Study
Sample - Population 
of interest, sample 
size
Study Design Study Methods Major Finding(s) Strengths Limitations
Appendix
Voorhees, A. S., 
Gold, L. S., Leb-
wohl, M., Strober, 
B., Lynde, C., 
Tyring, S., . . . 
Wang, Y. (2020). 
Efficacy and safe-
ty of apremilast in 
patients with 
moderate to se-
vere plaque psori-
asis of the scalp: 
Results of a phase 
3b, multicenter, 
randomized, 
placebo-con-
trolled, double-
blind study. Jour-
nal of the Ameri-
can Academy of 
Dermatology. 
doi:10.1016/
j.jaad.2020.01.072 
To evaluate the 
efficacy and safety 
of apremilast for 
moderate to se-
vere scalp psoria-
sis. 
n = 303 Multicenter, ran-
domized, double-
blind, placebo-
controlled study
For the placebo-con-
trolled phase, study 
personnel randomly 
assigned patients (2:1), 
using a permuted block 
randomization and 
centralized interactive 
response technology, to 
receive apremilast 
30 mg twice daily or 
placebo for 16 weeks. 
To mitigate potential 
gastrointestinal adverse 
effects, doses were 
titrated over the first 
week of treatment (in 
10-mg increments). At 
week 16, all patients 
continued or switched 
to apremilast 30 mg 
twice daily through 
week 32, with dummy 
titration or titration 
during week 16 for 
patients initially ran-
domized to apremilast 
or placebo, respectively. 
The study sponsor, site, 
contract research 
organization personnel, 
and patients were 
blinded to treatment 
allocation through 
week 16; after week 16, 
the study sponsor, site, 
and contract research 
organization personnel 
directly involved with 
study conduct re-
mained blinded until 
the final database lock. 
The study drug was 
administered twice 
daily, approximately 
12 hours apart, without 
restriction of food or 
drink
There were 303 
randomized pa-
tients (placebo: 
n = 102; apremi-
last: n = 201). 
With apremilast, 
significantly more 
patients achieved 
Scalp Physician 
Global Assessment 
(43.3% vs 13.7%), 
Scalp Itch NRS 
(47.1% vs 21.1%), 
and Whole Body 
Itch NRS (45.5% 
vs 22.5%) re-
sponse, and signif-
icantly greater 
DLQI improve-
ment was ob-
served versus 
placebo (-6.7 vs 
-3.8; all P < .0001). 
Common adverse 
events with 
apremilast were 
diarrhea (30.5%), 
nausea (21.5%), 
headache (12.0%), 
and vomiting 
(5.5%).
- Study consists of 
a generally large 
sample size, fur-
ther influencing 
the reliability and 
correlation of the 
study. 
- Patients with 
mild psoriatic 
disease were not 
observed
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